The April 30, 2026 FDA proposal would further close the 503B bulks pathway permanently
So I feel like this is at best the end of the beginning rather than the beginning of the end of the work that weve gotta do to try and understand how do we use incretin therapies more effectively in our high-risk patients to achieve a whole range of clinical benefits
They can provide personalized advice, consider alternative treatments, or adjust the medication dosage
When you cannot tolerate solid food, a GLP-1 protein shake provides critical amino acids in a form that is much easier on the stomach
Acid Reflux on Mounjaro: Why It Happens and How to Manage It Common Side Effects 05 May 2026 By Acid reflux, heartburn, and gastro-oesophageal reflux disease (GORD) are among the most commonly reported gastrointestinal complaints during GLP-1 receptor agonist treatment
It has also been known to make food less appealing, potentially ruining the enjoyment of eating altogether